Reference
Carr, Tara F, and Monica Kraft. “Management of Severe Asthma before Referral to the Severe Asthma Specialist”. J. Allergy Clin. Immunol. Pract., vol. 5, no. 4, July 2017, pp. 877–886.
Abstract
Severe asthma is associated with significant morbidity and can
be challenging to assess and control, due to heterogeneity of
disease, complexity of diagnosis, and impact of comorbidities. A
structured approach to the assessment and management of severe
asthma may be helpful to the practicing clinician. First, it is
important to confirm a diagnosis of asthma. In patients who are
either not responding to treatment, or who require high doses of
medication to control symptoms, it is highly possible that
disease mimickers or comorbidities are present and can inhibit
therapeutic responsiveness. The assessment and management of
common comorbidities of asthma may dramatically impact disease
control and thus medication requirement. Determining medication
adherence and optimizing drug dose and delivery may separate out
truly severe asthmatics from those not using medications
regularly or properly. Next, although true personalized medicine
for severe asthma is not yet realized, for those individuals
with severe asthma, phenotypic characteristics of each patient
may guide which therapeutic options may be most effective for
that patient. Finally, evaluation and management of severe
asthma at a referral center can add additional phenotyping,
therapeutic, and diagnostic strategies.